title: More on Reevaluating PSA Testing Rates in the PLCO Trial.
authors.affiliation: National Cancer Institute, Bethesda, MD pinskyp@mail.nih.gov.
authors.forename: Paul
authors.initials: P
authors.lastname: Pinsky
authors.affiliation: National Cancer Institute, Bethesda, MD pinskyp@mail.nih.gov.
authors.forename: Philip
authors.initials: P
authors.lastname: Prorok
mesh_terms: D051517:Digital Rectal Examination; D055088:Early Detection of Cancer; D006801:Humans; D008403:Mass Screening; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms
chemical_list: D017430:Prostate-Specific Antigen